Carotuximab

From WikiMD's Wellness Encyclopedia



Carotuximab (INN[1]) (TRC-105) is a chimeric monoclonal antibody designed for the treatment of cancer.

This drug was developed by Tracon Pharmaceuticals Inc.[2]

It is at Phase III trials for angiosarcoma.

References[edit | edit source]

Contributors: Prab R. Tumpati, MD